Business review P06P53 Governance and remuneration P54P90 Financial statements P91P182 Shareholder information P183P204 181 Notes to the company balance sheet UK GAAP D Fixed assets 2009 2008 m m Shares in GlaxoSmithKline Services Unlimited 613 613 Shares in GlaxoSmithKline Holdings One Limited 18 18 Shares in GlaxoSmithKline Holdings Limited 17,888 17,888 Shares in GlaxoSmithKline Mercury Limited 33 18,552 18,519 Capital contribution relating to share based payments 1,080 1,041 19,632 19,560 E Debtors 2009 2008 m m Amounts due within one year: UK Corporation tax recoverable 228 268 Amounts owed by Group undertakings 116 98 344 366 Amounts due after more than one year: Amounts owed by Group undertakings 392 599 736 965 F Creditors 2009 2008 m m Amounts due within one year: Bank overdraft 8 8 Amounts owed to Group undertakings 2,606 4,625 Other creditors 454 670 3,068 5,303 The company has guaranteed debt issued by one of its subsidiary companies for which it receives an annual fee from the subsidiary.
In aggregate, the company has issued guarantees over $11 billion of debt instruments.
The amount due from the subsidiary companies in relation to these guarantee fees will be recovered over the life of the bonds and are disclosed within debtors see Note E. GSK Annual Report 2009
